2020 Launched Products
Zeta Pharma launches “Empacoza” type 2 diabetes medicine in Egyptian Market, In presence of famous Egyptian professors of Internal medication and endocrinology, from all Egyptian universities, gathered in Cairo attended the dispatch meeting of “Empacoza” the most recent type 2 diabetes medicine, which contains the dynamic fixing (Empagliflozin).
The most recent literatures showed that this medication, notwithstanding its high adequacy in glycemic control, likewise benefits the heart and decreases the frequency of cardiovascular demise. It likewise gives kidney security and helps weight reduction in diabetic patients.
A gathering of senior medical services experts took part on this occasion and gave significant patient guidelines with respect to this current medication’s best use.
Prof. Sherif Hafez, Professor of Internal Medicine and Diabetes at Cairo University, affirmed the significance of tight control on blood glucose to stay away from genuine intricacies. He additionally featured the requirement for early glycemic control and instructed keeping up close control concerning pulse and cholesterol levels.
Prof. Megahid Abu Al-Majd, Professor of Internal Medicine and Diabetes at Mansoura University, commended the jump that happened in the administration of diabetes with the rise of Empagliflozin, which secures the heart and kidneys and helps in getting more fit.
Zeta Pharma launched its new product, NorPregna pills for emergency contraceptive purposes.